![CEimpact Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/5e/ae/42/5eae4208-b706-0adc-12fb-75292fc9ea63/mza_14075584767013252581.jpg/100x100bb.jpg)
Hypercoagulability with COVID-19 infection | GameChangers
CEimpact Podcast
English - May 22, 2020 04:01 - 21 minutes - 14.4 MBCourses Education Science ceimpact podcast precept2practice level up gamechangers pharmacy cme cpe pharmacology ceimpact geoff wall Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. Emerging evidence suggests that patients with COVID infection may be hypercoagulable and prone to clotting. Listen in as we discuss the evidence surrounding this issue and how to address therapeutic issues in anticoagulation in this population.This episode is accredited for CPE. This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3he73SF See omnystudio.com/listener for privacy information.